NATUREX : Naturex announces its eligibility for PEA-PME and inclusion in the new Euronext index, CAC(R) PME
Avignon, 28 March 2014 - Naturex, world leader in speciality plant-based ingredients, informs shareholders of its eligibility for French equity savings vehicles for small and mid caps (PEA-PME) qualifying for special tax benefits according to new criteria applicable in France (Decree No. 2014-283 of 4 March 2014) and its inclusion in the Euronext index CAC® PME.
Based on its annual consolidated financial statements, Naturex fully meets the criteria established by the French Ministry of Economy and Finance:
|PEA-PME eligibility criteria||Naturex Group consolidated data|
|Less than 5,000 employees||1,500 employees|
|Less than €1.5 million in revenue||€320.8 million|
|Less than €2 billion in assets||€471.6 million1|
In consequence, Naturex shares are eligible for inclusion in PEA-PME. The PEA-PME is a new form of equity savings vehicle created on 1 January 2014. Supplementing the standard equity savings vehicle, it qualifies for the same tax advantages and is subject to the same operating rules except that investments in PEA-PME are destined exclusively to finance listed and unlisted French and European SMEs and mid-size companies (ETIs)2.
Furthermore, Naturex was selected to be included in the new index introduced by Euronext, CAC® PME that tracks the performances of 20 to 40 French PEA PME eligible companies listed on Euronext and Alternext markets in Paris. Its components are based on local trade volumes with the weight of individual stock capped at 7.5%. The CAC®PME is calculated in real time and its composition and weightings will be revised quarterly. It is listed under ISIN code FR0011710375 and the trading symbol CAPME.
"Naturex is proud to meet the criteria for PEA-PME eligibility and to be among the 40 stocks selected to be included in this new Euronext CAC® PME index. Inclusion in this index highlights both the confidence of our shareholders over many years and Naturex's positioning among dynamic and innovative French and European SMEs and mid-size companies", commented Thierry-Bertrand Lambert, Naturex's Chief Financial Officer.
You can receive all financial information of Naturex free of charge by signing up at: www.naturex.com
- Next press release
2013 annual results 31 March 2014
- SFAF analysts meeting of 2 April 2014
Naturex will present its 2013 consolidated annual results at the analysts meeting of 2 April 2014 at 10:00 a.m. at NYSE Euronext in Paris.
Naturex has been listed since October 1996 on NYSE Euronext in Paris, Segment B
|Total number of shares comprising the share capital: 7,845,705 (February 2014)
Naturex is a component of the CAC®PME, CAC Small and Gaïa indexes.
Naturex is eligible for the "long only" Deferred Settlement Service (SRD).
Naturex established a Sponsored Level 1 American Depositary Receipt (ADR) program in the United States. Under this facility, Naturex's ADRs are traded over-the-counter in the United States under the symbol NTUXY.
SYMBOL: NRX - Reuters: NATU.PA - Bloomberg: NRX:FP - DR Symbol: NTUXY
Naturex is the global leader in speciality plant-based natural ingredients. The Group is organised around three strategic markets (food & beverage, nutrition & health and personal care) and produces and markets speciality plant-based ingredients for the food, nutraceutical, pharmaceutical and cosmetic industries.
Naturex's head office is based in Avignon. The company employs more than 1,400 people with 8 sourcing offices located throughout the world and high-performance manufacturing operations across 15 sites in Europe, Morocco, the United States, Brazil, Australia and India. It also has a global commercial presence through a dedicated network of sales offices in more than 20 countries.
Chairman and Chief Executive Officer
Tel.: +33 (0)4 90 23 96 89
Chief Financial Officer
Tel.: +33 (0)4 90 23 96 89
Tel.: +33 (0)4 90 23 78 28
|Anne Catherine Bonjour
Actus Finance Press Relations
Tel.: +33 (0)1 53 67 36 93
1 At 31 December 2012 based on the 2012 consolidated accounts; the annual financial statements of Naturex S.A and the Group consolidated financial statements (financial statements and notes) will be approved by the Board of Directors of the company on 28 March 2014
2 ETI: "Entreprise de Taille Intermédiaire" or mid-size company defined under French law (INSEE) as a company having between 250 and 4,999 employees with less than €1.5 billion in revenue and less than €2 billion in total assets.
Communiqués au titre de l'obligation d'information permanente :
- Autres communiqués Communiqué intégral et original au format PDF :